查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499443

药物筛检市场：按产品类型、样本类型、最终用户划分 - 2024-2030 年全球预测

Drug Screening Market by Product (Consumables, Instruments, Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药物筛检市场规模为86.6亿美元，2024年达98.9亿美元，预计2030年将达到222.5亿美元，复合年增长率为14.42%。

药物筛检是测试尿液、血液、头髮或唾液等生物样本以识别是否有非法或处方药物或其代谢物的过程。这个过程通常用于各种环境，包括就业、刑事司法、体育和成瘾治疗，以确保个人遵守毒品政策或不含违禁物质。提高职场的安全性和合规性、全球处方药和非处方药消费量的增加以及强制进行药物测试的更严格的政府法规和组织政策是主要驱动因素。然而，先进测试技术的高成本和药物检测窗口的可变性可能会阻碍采用。然而，更灵敏和快速测试的开拓以及对行动和现场药物测试服务不断增长的需求预计将为市场成长创造潜在机会。

主要市场统计
基准年[2023] 86.6亿美元
预测年份 [2024] 98.9亿美元
预测年份 [2030] 222.5亿美元
复合年增长率（%） 14.42%

区域洞察

由于职场安全、效率以及公共卫生意识的增强，亚太地区的药物筛检正在显着增长。由于亚太地区国家人口多样化且药物滥用率各异，因此对药物检测服务的需求因地区而异。随着政府机构努力遏制药物滥用，对药物筛检设备和服务的需求不断增长。由于严格的监管要求和职场安全法规的执行，美洲地区是药物筛检的发展中市场之一。阿片类药物危机让药物检测受到更多关注。在美洲，专利註册不断发展，以反映药物检测方法和套件的技术创新。欧盟国家非常重视公共卫生和职场安全，并制定了严格的药物筛检实务法律。资料保护条例也影响职场药物检测管理。在毒品法严格的中东国家，药物筛检市场波动很大，而且往往受到政府政策的强制。非洲的药物筛检市场正在兴起，人们对药物筛检的认识和需求正在不断增加，这主要受到公共卫生宣传活动和国际职场安全标准的影响。欧洲国家在研发方面投入巨资，开发了符合高精度和可靠性标准的先进药物筛检技术。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在药物筛检市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对药物筛检市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在药物筛检市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球娱乐和处方药物滥用激增
      • 提高职场安全性和合规性
      • 要求进行药物测试的政府法规或组织政策
    • 抑制因素
      • 操纵药物筛检结果的可能性
    • 机会
      • 创新药物筛检技术与套件的开发
      • 对移动和现场药物检测服务的需求增加
    • 任务
      • 缺乏针对整个经济范围的药物筛检的标准法规结构
  • 市场区隔分析
    • 产品：非侵入性且可快速提供结果的口腔液检测设备的使用正在迅速增加
    • 最终使用者：药物筛检在戒毒治疗中心的重要用途
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章药物筛检市场：副产品

  • 消耗品
  • 装置
  • 服务

第七章依样本类型分類的药物筛检市场

  • 呼吸样本
  • 头髮样本
  • 口腔液样本
  • 尿液样本

第八章药物筛检市场：依最终用户分类

  • 刑事司法系统与执法
  • 药物检测实验室
  • 戒毒治疗中心
  • 医院
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 职场

第九章美洲药物筛检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药物筛检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲药物筛检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 创新合作推出虚拟药物筛检平台
    • 推出 Accurate Background 的先进药物和健康筛检服务
    • bioXcelerate 利用人工智慧驱动的筛检工具彻底改变药物发现
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-DD6333AE5B92

[199 Pages Report] The Drug Screening Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 14.42% to reach USD 22.25 billion by 2030.

Drug screening is the process of checking biological samples, such as urine, blood, hair, or saliva, to identify the existence of illegal or prescription drugs or their metabolites. This process is commonly used in various contexts, including employment, criminal justice, sports, and treatment of addiction, ensuring individuals are compliant with drug policies or are free from prohibited substances. Increased safety and compliance in workplaces, increasing consumption of both prescription and non-prescription drugs worldwide, and strict regulations by governments and organizational policies mandating drug testing are significant drivers. However, the high costs of advanced testing technologies and variability in drug detection windows can deter adoption. Nevertheless, the development of more sensitive and faster tests and the growing need for mobile and on-site drug testing services are expected to create potential opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 22.25 billion
CAGR (%) 14.42%

Regional Insights

The Asia-Pacific region has seen substantial growth in drug screening due to increasing awareness about the safety and efficiency of workplaces and public health. APAC countries have diverse populations and exhibit varying rates of substance abuse, which influences the need for drug testing services differently across the region. Government agencies have advanced their efforts in curbing drug abuse, translating into a higher need for drug screening devices and services. The Americas region is one of the evolved markets for drug screening due to strict regulatory requirements and the enforcement of workplace safety regulations. The opioid crisis has further heightened the focus on drug testing. The Americas region continues evolving in patent registrations, reflecting ongoing drug testing methodologies and kit innovations. EU countries focus strongly on public health and workplace safety, with rigorous laws governing drug screening practices. The data protection regulation also impacts the administration of workplace drug testing. With stringent anti-drug laws, countries in the Middle East have a variable market for drug screening, often mandated by government policies. Africa's drug screening market is emerging, with an increasing awareness and need for drug screening primarily influenced by public health campaigns and international workplace safety standards. European countries invest significantly in research and development, which has led to advanced drug screening technologies designed to meet high accuracy and reliability standards.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug Screening Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Surge in both recreational and prescription drug misuse globally
      • Increased safety and compliance in workplaces
      • Regulations by governments and organizational policies mandating drug testing
    • Market Restraints
      • Possibility of manipulation of drug screening results
    • Market Opportunities
      • Development of innovative drug screening technologies and kits
      • Growing demand for mobile and on-site drug testing services
    • Market Challenges
      • Lack of standard regulatory framework for drug screening across economies
  • Market Segmentation Analysis
    • Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
    • End User: Significant utilization of the drug screening in the drug treatment centers
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Screening Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Screening Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Innovative Partnership Launches Virtual Drug Screening Platform

eMed, a digital health company, partnered with i3Screen, an established provider of drug screening solutions, to introduce virtual drug testing services. This new platform is designed to facilitate remote drug screening, utilizing eMed's patented technology to ensure the integrity and confidentiality of the testing process. The service is tailored for employers and organizations looking to implement drug testing efficiently while minimizing the need for physical interactions. This partnership enhances the accessibility and effectiveness of drug testing programs and aligns with current trends toward more digital and remote healthcare solutions. [Published On: 2024-05-15]

Launch of Accurate Background's Advanced Drug and Health Screening Services

Accurate Background, a provider of background and identity services, has recently expanded its offerings by launching a new, enhanced drug and health screening service. This service is designed to accommodate the growing demand for efficient and comprehensive employee screening processes. With this advancement, the company introduces a streamlined platform integrating enhanced drug testing methods with robust health screening capabilities. Employers benefit from this service as it provides a more efficient way to conduct pre-employment health assessments, enabling faster and more informed hiring decisions. This initiative underscores Accurate Background's commitment to innovating within the industry and enhances its ability to support employers in maintaining a safe and compliant workplace. [Published On: 2024-04-04]

bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool

bioXcelerate announced the launch of a cutting-edge artificial intelligence (AI) tool designed to expedite the drug discovery process significantly. This innovative technology aims to streamline the early stages of drug development by enhancing the screening of chemical compounds and expediting the identification of promising drug candidates. By leveraging AI, bioXcelerate anticipates reducing the time and costs traditionally associated with these phases, potentially accelerating the timeline for bringing new drugs to market. This breakthrough is instrumental in ushering in a new era of faster, more efficient drug discovery, particularly beneficial in addressing rapidly evolving global health challenges. [Published On: 2024-03-24]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Screening Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Merck KGaA, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Pfizer Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Sartorius AG, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Assay Kits
      • Calibrators & Controls
      • Sample Collection Tubes
    • Instruments
      • Analytical Instruments
        • Breathalyzers
        • Fuel-Cell Breathalyzers
  • Semiconductor Breathalyzers
        • Chromatography Instruments
        • Immunoassay Analyzers
      • Rapid Testing Devices
        • Oral Fluid Testing Devices
        • Urine Testing Devices
        • Dip Cards
  • Drug Testing Cassettes
  • Drug Testing Cups
  • Services
  • Sample Type
    • Breath Samples
    • Hair Samples
    • Oral Fluid Samples
    • Urine Samples
  • End User
    • Criminal Justice Systems & Law Enforcement Agencies
    • Drug Testing Laboratories
    • Drug Treatment Centers
    • Hospitals
    • Individual Users
    • Pain Management Centers
    • Schools & Colleges
    • Workplaces
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in both recreational and prescription drug misuse globally
      • 5.1.1.2. Increased safety and compliance in workplaces
      • 5.1.1.3. Regulations by governments and organizational policies mandating drug testing
    • 5.1.2. Restraints
      • 5.1.2.1. Possibility of manipulation of drug screening results
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of innovative drug screening technologies and kits
      • 5.1.3.2. Growing demand for mobile and on-site drug testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standard regulatory framework for drug screening across economies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
    • 5.2.2. End User: Significant utilization of the drug screening in the drug treatment centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Drug Screening Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Screening Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Schools & Colleges
  • 8.9. Workplaces

9. Americas Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Innovative Partnership Launches Virtual Drug Screening Platform
    • 12.3.2. Launch of Accurate Background's Advanced Drug and Health Screening Services
    • 12.3.3. bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG SCREENING MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 98. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 99. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 111. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 112. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 113. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 114. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 115. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 116. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 117. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 118. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 119. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 127. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 128. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 129. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 130. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 131. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 132. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 133. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 134. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 135. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 136. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 137. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 144. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 145. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 148. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 149. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 150. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 151. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 152. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 153. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 154. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 155. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 162. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 163. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 166. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 167. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 168. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 169. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 170. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 171. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 172. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 173. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 180. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 181. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 182. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 220. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 222. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 223. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 224. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 225. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 226. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 227. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 228. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 229. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 238. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 239. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 240. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 241. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 242. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 243. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 244. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 245. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 246. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 247. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 248. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 249. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 256. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 257. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 258. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 259. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 260. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 261. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 262. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 263. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 264. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 265. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 266. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 267. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 274. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 275. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 276. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 277. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 280. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 281. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 282. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 283. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 284. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 285. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 292. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 293. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 294. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 295. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 296. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 297. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 298. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 299. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 300. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 301. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 302. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 303. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 310. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 311. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 312. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 313. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 314. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 315. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 316. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 317. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 318. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 319. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 320. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 321. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 328. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 330. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 331. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 332. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 333. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 334. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 335. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 336. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 337. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 338. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 339. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 346. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 347. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 348. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 349. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 350. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 351. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 352. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 353. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 354. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 355. SINGAPORE DRUG SCREENING MARKE